[{"AccountsPayableCurrent_0_Q2_USD":1613000.0,"OtherLiabilitiesCurrent_0_Q2_USD":136000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":30000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":16000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":3700000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-12144000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-6817000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":117337000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":7351000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":544400.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q2_shares":315400.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":8.71,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":136967.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":4480000.0,"OtherAssetsNoncurrent_0_Q2_USD":1436000.0,"GainsLossesOnSalesOfAssets_2_Q2_USD":-3000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":2675000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":48.1,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":12.48,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":37.36,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":831110.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":21.68,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":99932.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":263000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":807000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":14785000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":1346000.0,"AccruedIncomeTaxes_0_Q2_USD":20000.0,"ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_2_Q2_USD":4392000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":3193000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.08,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2555000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":2618000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":539000.0,"OperatingLeaseLiability_0_Q2_USD":3157000.0,"OperatingLeaseCost_2_Q2_USD":310000.0,"OperatingLeaseCost_1_Q2_USD":145000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":957000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":396000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1358000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":1385000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":1413000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":1441000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":11316000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":17309000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":81000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":297200000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":5496000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":38000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":807000.0,"IncreaseDecreaseInPrepaidRent_2_Q2_USD":2400000.0,"VariableLeaseCost_1_Q2_USD":15000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1570000.0,"ShareBasedCompensation_2_Q2_USD":1346000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-2255000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":117712000.0,"LiabilitiesCurrent_0_Q2_USD":5831000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":318145000.0,"Liabilities_0_Q2_USD":8449000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-366000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":706000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":5735000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3315000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.68,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.37,"Depreciation_2_Q2_USD":729000.0,"Depreciation_1_Q2_USD":394000.0,"CommonStockValue_0_Q2_USD":0.0,"CommonStockSharesOutstanding_0_Q2_shares":19664059.0,"CommonStockSharesIssued_0_Q2_shares":19664059.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":104164000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":291678000.0,"AssetsCurrent_0_Q2_USD":298539000.0,"Assets_0_Q2_USD":318145000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":831110.0,"AdditionalPaidInCapital_0_Q2_USD":360877000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":40000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-11293000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":34124.0,"NetIncomeLoss_1_Q2_USD":-6833000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":3454000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":7164000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":3639000.0,"PreferredStockValue_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":2061773.0,"PreferredStockSharesAuthorized_0_Q2_shares":20000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0,"OperatingIncomeLoss_2_Q2_USD":-12899000.0,"OperatingIncomeLoss_1_Q2_USD":-6954000.0,"OperatingExpenses_2_Q2_USD":12899000.0,"OperatingExpenses_1_Q2_USD":6954000.0,"DepreciationAndAmortization_2_Q2_USD":884000.0,"CommonStockSharesAuthorized_0_Q2_shares":80000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q2_USD":3679000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":17871648.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":18383941.0,"StockholdersEquity_0_Q2_USD":309696000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-51221000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":13215000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":117712000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1365000.0,"NetIncomeLoss_2_Q2_USD":-12174000.0,"VariableLeaseCost_2_Q2_USD":28000.0,"Ticker":"KRYS","CIK":"1711279","name":"KRYSTAL BIOTECH, INC.","OfficialName":"Krystal Biotech Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1834745088.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]